Anika Therapeutics ANIK Interest Income On Acquired Note Receivable
Interest Income On Acquired Note Receivable at other companies
Other financials
Where this comes from
Reported directly by Anika Therapeutics in its filing.
Tagged under the XBRL concept anik:InterestIncomeOnAcquiredNoteReceivable.
The official record: Anika Therapeutics’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Anika Therapeutics's interest income on acquired note receivable.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Anika Therapeutics's interest income on acquired note receivable?
- Anika Therapeutics (ANIK) reported interest income on acquired note receivable of $179K in Q1 2026.
- How has Anika Therapeutics's interest income on acquired note receivable changed year-over-year?
- Anika Therapeutics's interest income on acquired note receivable decreased by 20.1% year-over-year, from $224K to $179K.
- What does interest income on acquired note receivable mean?
- This represents the interest revenue generated from notes receivable that were obtained as part of a business acquisition or divestiture. It reflects the yield on non-operating financial assets held by the company. Monitoring this helps investors understand the contribution of non-core financial instruments to the company's overall cash flow profile.